Registered entities
Dbv Technologies Inc.
Reg. No. 147097299United States
DBV
Reg. No. 50103624911Latvia
DBV TECHNOLOGIES S.A.
Reg. No. 1613780United States
Innovation
7 patent families (1 granted) — focus: Human necessities; filing pace dormant. Cited 22 times.
| Year | Filings |
|---|---|
| 2016 | 2 |
Social engagement
Social engagement: 20.4K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
18 investors on record; lead investors include ALK-Abello, Sofinnova Partners, Apax, Lundbeck Foundation; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 22% |
| Private equity | 5 | 28% |
| Bank & private debt | 1 | 6% |
| Other / undisclosed | 8 | 44% |
Hiring activity
Hires occasionally
3 roles tracked across 2 of the last 12 months
22 Nov 2025 · Medical Science Liaison · Chicago
Based on job postings tracked across public sources.
Recent activity
29 Jun 2026
Event
conference call and live webcast on BLA submission for VIASKIN® Peanut Patch
23 Jun 2026
Recognition
regulatory
9 Jun 2026
Event
European Academy of Allergy and Clinical Immunology - EAACI Congress 2026